Author: | Drilon, A. |
Review Title: | Management of patients with NTRK fusion-positive lung cancer |
Keywords: | genetics; protein kinase inhibitor; lung neoplasms; pathology; protein kinase inhibitors; lung tumor; oncogene proteins, fusion; interview; disease management; drug therapy; therapy; protein tyrosine kinase a; receptor, trka; humans; human; oncogene fusion protein |
Journal Title: | Clinical Advances in Hematology & Oncology |
Volume: | 22 |
Issue: | 6 Suppl. 6 |
ISSN: | 1543-0790 |
Publisher: | Millennium Medical Publishing, Inc |
Date Published: | 2024-07-01 |
Start Page: | 5 |
End Page: | 9 |
Language: | English |
PUBMED: | 38953727 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | This work is part of a larger series/topic titled "Efficacy and Safety of NTRK Inhibitors in Patients With NTRK Fusion–Positive Lung and Thyroid Cancers" (PMID: 38953725) -- Source: Scopus |